pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA) · news · pharmadog
← back to TEVA PHARMACEUTICAL INDUSTRIES LTD
News mentioning $TEVA
31
stories
1d
Kolon TissueGene cuts 37 US staffers after Phase 3 fail
biospace
1d
Federal appeals court revives part of Teva's IRA case as Austedo price cuts loom
endpoints
3d
Slate uses Fulcrum to vault onto Nasdaq with $245M financing for migraine trials
fiercebiotech
3d
Lilly pens $370M deal with OmniAb for ion channel collab, but details remain vague
fiercebiotech
7d
Zealand sells its rights to Takeda’s blood cancer drug for $100M ahead of FDA approval decision
fiercebiotech
14d
Judge signs off on Teva's $35M settlement over delayed inhaler generics
endpoints
15d
Attovia adds to biotech IPO momentum with $289M offering
biopharma dive
16d
Merck’s $11B anti-TL1A bet delivers 1 win, 1 loss in midphase inflammatory disease trials
fiercebiotech
21d
Chutes & Ladders—Legend CEO departs without successor in place
fiercebiotech
21d
Gerresheimer divests two businesses worth €1.5B; Resilience, Lilly boost injectable pen capacity
endpoints
22d
Teva is confident it has time to brace for tariffs on non-US generics
endpoints
24d
Argenx to acquire Forte in $2.2B deal for ‘differentiated’ immune drug
biopharma dive
28d
Biopharma layoffs must double in H2 for 2026 to match 2025 cuts
biospace
Jul 21, 26
Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge
fiercebiotech
Jul 16, 26
Spurred by deep cuts and M&A activity, H1 layoffs could oust 14,000+ in biopharma
biospace
Jul 15, 26
STAT+: Bipartisan lawmakers want to require U.S. to probe reliance on foreign-made drugs, ingredients
stat
Jul 15, 26
STAT+: Glenmark to pay $29.6 million to settle price-fixing allegations in long-running battle with states
stat
Jul 15, 26
STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and more
stat
Jul 14, 26
STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access
stat
Jul 14, 26
STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last year
stat
Jul 14, 26
Majority of new Ebola cases in eastern Congo are from unknown chains, as outbreak outpaces response
stat
Jul 14, 26
STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and more
stat
Jul 7, 26
MeiraGTx strikes royalty deal; Fore's 2023 Series D continues
endpoints
Jun 18, 26
cAMPfield lands $180M to build gut disease drug
biopharma dive
Jun 17, 26
A new Westlake-backed biotech takes aim at migraines
biopharma dive
Jun 11, 26
Camurus’ second CRL for acromegaly drug; Teva details workforce cuts
endpoints
Jun 5, 26
Study data convince Lundbeck to push new migraine drug forward
biopharma dive
Jun 1, 26
The hidden history of BPC-157, a favorite MAHA peptide
stat
Apr 30, 26
Avalyn's upsized IPO; Alector ends another study in GSK partnership
endpoints
Apr 30, 26
STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and more
stat
← prev
page 1 of 2
next →
